What is USANA Health Sciences's D&A?

USANA Health Sciences (USNA) reported D&A of $8.28M in Q1 2026.

How has USANA Health Sciences's D&A changed year-over-year?

USANA Health Sciences's D&A decreased by 0.7% year-over-year, from $8.34M to $8.28M.

What is the long-term trend for USANA Health Sciences's D&A?

Over 4 years (2021 to 2025), USANA Health Sciences's D&A has grown at a 25.7% compound annual growth rate (CAGR), from $13.04M to $32.56M.

Non-cash expense representing the systematic allocation of tangible asset costs (depreciation) and intangible asset costs (amortization) over their useful lives.

USANA Health Sciences USNA D&A

D&A at other companies

HerbalifeHLF

$29.4M-4.2%

BellRing BrandsBRBR

$4.2M0.0%

US FoodsUSFD

$119M+6.3%

Evommune EVMN

$4.58K-26.4%

SMP

The Simply Good Foods CompanySMPL

$4.31M+3.9%

Celsius Holdings, Inc.CELH

——

Segments

By segment

See full

Hiya$4.46M0.0%

Rise$211K—

Other financials

Income statement

See full

Revenue$250.2M+0.3%

Gross profit$190.8M-3.2%

Operating income$13.9M-11.5%

Net income$7.5M-20.1%

EPS (diluted)$0.41-16.3%

Balance sheet

See full

Cash & equivalents$165.7M-9.2%

Total debt$18.0M+10.8%

Total equity$543.6M+2.6%

Total assets$739.0M-1.0%

Cash flow

See full

Operating cash flow$9.8M-37.0%

CapEx$2.6M-5.6%

Free cash flow$7.1M-43.9%

Valuation

See full

Market cap$363.35M-36.1%

P/E18.1×+7.8×

P/S0.4×-0.3×

Profitability

See full

Gross margin77.6%-3.0pp

Operating margin3.8%-2.7pp

Net margin1.9%-4.4pp

FCF margin5.7%-1.1pp

Returns & leverage

See full

Return on equity3.2%-7.6pp

Debt / equity0×0.0×

Current ratio2.5×+0.5×

Where this comes from

Reported directly by USANA Health Sciences in its filing.

Tagged under the XBRL concept us-gaap:DepreciationDepletionAndAmortization.

The official record: USANA Health Sciences’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about USANA Health Sciences's d&a.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is USANA Health Sciences's D&A?: USANA Health Sciences (USNA) reported D&A of $8.28M in Q1 2026.
How has USANA Health Sciences's D&A changed year-over-year?: USANA Health Sciences's D&A decreased by 0.7% year-over-year, from $8.34M to $8.28M.
What is the long-term trend for USANA Health Sciences's D&A?: Over 4 years (2021 to 2025), USANA Health Sciences's D&A has grown at a 25.7% compound annual growth rate (CAGR), from $13.04M to $32.56M.
What does D&A mean?: Non-cash expense representing the systematic allocation of tangible asset costs (depreciation) and intangible asset costs (amortization) over their useful lives.